Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 3 minute read Pharma Industry News Game-changing EDQM certification propels SMS Pharmaceuticals into Europe’s Ibuprofen market SMS Pharmaceuticals Limited has officially received the coveted EDQM certification, a milestone that positions the Indian-based pharmaceutical giant… byPallavi MadhirajuOctober 1, 2024